Skip to main content
. 2022 Dec 23;7(2):100130. doi: 10.1016/j.shj.2022.100130

Table 3.

Clinical outcomes of patients with severe tricuspid regurgitation

Clinical outcome Total population (n = 435)
All-cause mortality, n (%) 89 (20.5%)
Heart failure hospitalization, n (%) 153 (35.4%)
Major intervention, n (%) 17 (3.9%)
 Heart transplant, n (%) 2 (0.46%)
 Left ventricular assist device, n (%) 1 (0.23%)
 Tricuspid valve replacement, n (%) 11 (2.5%)
 Biventricular pacemaker, n (%) 3 (0.69%)